Tracking Cathie Wood: Continued investments in autonomous driving company AUR and AI healthcare stock TEM, while significantly selling off traditional SaaS companies

Overnight and into this morning, as investors positioned themselves ahead of NVIDIA's highly anticipated Q4 earnings report, the three major U.S. stock indexes rose together for the second consecutive trading day. After hours, NVIDIA’s results and financial guidance both exceeded expectations, but the market still seems to be grappling with the massive capital expenditures by hyperscale cloud service providers.

Based on overnight actions by 'Wood姐' (Cathie Wood), she continues to aggressively divest from traditional SaaS assets, redirecting the proceeds towards leading names in embodied AI (physical AI) and AI-driven precision healthcare.

Buying focus: Continued bets on autonomous driving and AI healthcare.

Cathie Wood has significantly increased her position in a commercial autonomous driving technology company, $Aurora Innovation (AUR.US)$ as well as a warehouse automation leader, $Symbotic (SYM.US)$ In terms of robotics and embodied AI, ARK’s investment strategy aligns closely with the ultimate trajectory of industrial evolution: bypassing increasingly competitive component manufacturing stages, and directly investing in top-tier companies that use 'integrated systems' as their commercial platform and 'embodied intelligence' as their long-term competitive advantage. SYM’s closed-loop hardware and software solutions in automated warehousing, along with AUR’s heavy truck platforms for trunk logistics, are excellent carriers for embodied intelligence continuously processing data and training algorithms in real-world scenarios.

Additionally, she heavily increased her stake in an AI healthcare data company, $Tempus AI (TEM.US)$ and an organ transplant precision diagnostics company, $CareDx (CDNA.US)$ This indicates that capital is actively seeking breakout opportunities for large-scale commercialization of AI models within high-barrier vertical industries. Tempus AI focuses on applying AI to massive clinical genomic data analysis, and such precision medicine targets with deep data moats are becoming a new favorite in ARK's application layer.

Cathie Wood slightly increased her position in the leading Latin American e-commerce company $MercadoLibre (MELI.US)$ , as a continuation of the strategic allocation in high-quality emerging market assets.

Sell side: Continued reduction of SaaS stocks and non-core consumer assets

Cathie Wood sold over a million shares overnight $PagerDuty (PD.US)$ , which indicates that in the era of AI large models, traditional IT operations and incident response SaaS that lack deep AI restructuring and cannot prove exponential growth on the revenue side are seeing their growth elasticity rapidly diminish.

Additionally, she reduced her holdings in the image-based social platform $Pinterest (PINS.US)$ , the sports betting giant $DraftKings (DKNG.US)$ , and the shared accommodation $Airbnb (ABNB.US)$ . In the current market environment dominated by 'hardcore technology,' pure consumer internet and entertainment assets have deviated from ARK's main focus on 'disruptive innovation.' The ongoing sale of such assets aims to further enhance the purity of the portfolio within the core innovation cycle.

While making significant investments in Tempus AI, she trimmed positions in some traditional biotech and gene-editing companies ( $Amgen (AMGN.US)$ 、 $Vertex Pharmaceuticals (VRTX.US)$ 、 $Beam Therapeutics (BEAM.US)$ The position adjustment within the healthcare sector reflects a 'weeding out the weak and retaining the strong' strategy, along with capital rotation.

Futubull's [Opportunities Page] has launched a feature to track celebrity portfolio opportunities! Choose from multiple celebrity portfolios, one-click follow the moves of top investors, precisely lock in high-quality stocks, and invest with greater confidence!

406K Views